FARIDOXORUBICIN

UNII:	7XPB9B6MUA
Type:	INGREDIENT SUBSTANCE
Formula:	C₄₁H₄₄N₄O₁₄
Preferred Substance Name:	FARIDOXORUBICIN
InChIKey:	CNGRCGLLHXRRTQ-SXSFFGRISA-N
GSRS Full Record:	7XPB9B6MUA i

1841402-73-0
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[[N-(4-pyridinylcarbonyl)-D-alanyl-L-prolyl]amino]-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-
AVA-6000
AVA-6000 (FAP-ACTIVATED DOXORUBICIN PRODRUG)
AVA6000
Faridoxorubicin
N-[(2R)-1-[(2S)-2-[[(2S,3S,4S,6R)-3-hydroxy-2-methyl-6-[[(1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]pyridine-4-carboxamide
faridoxorubicin [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

FARIDOXORUBICIN

Synonyms and Mappings

Resources